Chemoprevention of severe neonatal hyperbilirubinemia

Seminars in Perinatology

Volumn 28, Issue 5, 2004, Pages 365-368

  Drummond, George S ^a,b   Kappas, Attallah ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Neptune NJ 07753 6807   (United States)

Author keywords

heme oxygenase inhibitors; hyperbilirubinemia; stannsoporfin

Indexed keywords

BILIRUBIN; HEME OXYGENASE; MESOPORPHYRIN TIN; PENICILLAMINE; PORPHYRIN COBALT; PROTOPORPHYRIN; PROTOPORPHYRIN CHROMIUM; PROTOPORPHYRIN MANGANESE; PROTOPORPHYRIN ZINC; STANNSOPORFIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVITY; FOLLOW UP; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIDE EFFECT;

EID: 10344224021     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2004.09.004     Document Type: Review

References (21)

1. T.B. Newman, M.J. Maisels Kernicterus in otherwise healthy, breast-fed term newborns Pediatrics 96 1995 370 733
2. T. Valaes Pharmacological approaches to the prevention and treatment of neonatal hyperbilirubinemia M.J. Maisels J.F. Watchko Neonatal Jaundice. Harwood Academic Press. Monographs In Clinical Pediatrics 11 2000 205 213
3. S.L. Vaisman, L.M. Gartner Pharmacologic treatment of neonatal hyperbilirubinemia Clin Pernatol 2 1975 37 58
4. T. Valaes, K. Harvey-Wilkes Pharmacologic approaches to the prevention and treatment of neonatal hyperbilirubinemia Clin Perinatol 17 1990 245 273
5. R. Tenhunen, H.S. Marver, R. Schmid The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase Proc Natl Acad Sci USA 61 1968 748 755
6. M.D. Maines Heme oxygenase; function, multiplicity, regulatory mechanisms and clinical applications FASEB J 2 1988 2557 2568
7. D.K. Stevenson, S.R. Hintz, R.I. Wong Drugs for hyperbilirubinemia S.J. Yaffe J.V. Aranda Neonatal and Pediatric Pharmacology (ed 3) 2004 W.B. Saunders New York, NY 197 208
8. M.D. Maines, A. Kappas Enzymatic oxidation of cobalt protoporphyrin. IX. Observations on the mechanism of heme oxygenase Biochemistry 16 1977 419 423
9. A. Kappas, G.S. Drummond Control of heme metabolism with synthetic metalloporphyrins J Clin Invest 77 1986 335 339
10. 4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme metabolism Arch Biochem Biophys 255 1987 64 74
11. G.S. Drummond, T.N. Valaes, A. Kappas Control of bilirubin production by synthetic heme analogs Pharmacologic and toxicologic considerations. 16 1996 572 579
12. T. Valaes, S. Petmezaki, C. Henschke Control of jaundice in preterm newborns by an inhibitor of bilirubin production Studies with stannsoporfin Pediatrics 93 1994 1 11
13. A. Kappas, G.S. Drummond, C. Henschke Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production and phototherapy in controlling hyperbilirubinemia in term and near-term newborns Pediatrics 95 1995 468 474
14. J.C. Martinez, H.O. Garcia, L.E. Otheguy Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production, Sn-mesoporphyrin Pediatrics 103 1999 1 5
15. V.K. Bhutani, L.D. Meloy, R.L. Poland Randomized placebo-controlled trial of stannsoporfin (SnMP) to prevent severe hyperbilirubinemia in term and near term infants 2004 PAS Annual Meeting. San Francisco Abstract #2542
16. Valaes T, Drummond GS, Kappas A: Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborns using an inhibitor of bilirubin production, Pediatrics. 101:E1, 1998. URL: http://www.pediatrics.org/ cgi/contents/full/101/5/el, 1998
17. A. Kappas, G.S. Drummond, T. Valaes A single dose of Sn-mesoporphyrin prevents development of significant hyperbilirubinemia in glucose-6- phosphate dehydrogenase deficient newborns Pediatrics 108 2001 25 30
18. A. Kappas, D.P. Munson, J.R. Marshall Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion Pediatrics 108 2001 1374 1377
19. C. Goldberg, B. Levinson, M. Mahoney Use of stannsoporfin as an adjuvant to phototherapy to prevent need for exchange transfusion in near term and term infants 2004 PAS Annual Meeting. San Francisco Abstract #2605
20. R.A. Galbraith, G.S. Drummond, A. Kappas Suppression of bilirubin production in the Crigler-Najjar Type 1 syndrome Studies with the heme oxygenase inhibitor tin-mesoporphyrin Pediatrics 93 1994 1 11
21. A. Kappas A method for interdicting the development of severe jaundice by inhibiting bilirubin production Pediatrics 113 2004 119 126